U.S., Feb. 22 -- ClinicalTrials.gov registry received information related to the study (NCT06840925) titled 'A Clinical Trial to Evaluate the Relative Bioavailability of PRAX-628' on Jan. 29.
Brief Summary: A phase I clinical trial to evaluate the relative bioavailability of PRAX-628 tablet formulation compared to capsule formulation
Study Start Date: March 24
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: PRAX-628
Once daily oral
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Praxis Precision Medicines
Published by HT Digital Content Services with permission from Health Daily Digest....